Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VG081821AC monotherapy for early-to-mid-stage Parkinson's disease
CTR20261247Phase 2Active
- Sponsor
- Chunhe Pharmaceutical Technology
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VG081821AC in Parkinson's disease (PD), sponsored by Chunhe Pharmaceutical Technology. Started Jul 2026; status: active.
02
Drugs
VG081821AC
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20261247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261247.